logo
Why many investors are turning to AI tools

Why many investors are turning to AI tools

National Post2 days ago
This article was created by StackCommerce. Postmedia may earn an affiliate commission from purchases made through our links on this page.
Article content
Canada's retail investors are increasingly turning to AI tools to sharpen decision-making. A 2025 behavioral study by the Ontario Securities Commission found Canadians follow AI-generated investment suggestions just as readily as human advisors. That willingness coincides with a surge in cross-border investing: in May, Canadian investors funneled $13.4 billion into foreign securities, including a record $11.5 billion in U.S. equities.
Article content
Article content
Article content
In this context, platforms like Amsflow AI Financial Analysis Pro Plan offer timely tools for investors seeking clarity. Amsflow provides AI-powered screening across 70,000 global assets, backed by more than a century of historical data. Tools such as its natural-language agent 'Lisa' and pivot-point engine 'X-Ray' enable users to spot market-moving trends and filter using over 550 metrics and 8,000 customizable parameters.
Article content
How Amsflow AI simplifies investing
Article content
Its portfolio dashboard includes real-time alerts for technical shifts or earnings surprises, while shared watchlists and team-driven discussions help professionals collaborate. Heat maps and correlation visuals simplify comparisons across asset classes, and scheduled digests deliver concise updates, with no data overload.
Article content
Given Canada's current backdrop—strong retail demand abroad, sustained equity volatility and regulators adapting to AI adoption—Amsflow becomes more than just a toy for tech-savvy users. It's a decision-support tool aligned with an evolving investor ecosystem in mind.
Article content
For Canadian professionals and serious retail investors, that AI edge that regulators now study is no longer theoretical. It's applicative, affordabl and built for this moment.
Article content
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Imagen Network Builds Adaptive Content Filters Using Grok to Boost Engagement Quality
Imagen Network Builds Adaptive Content Filters Using Grok to Boost Engagement Quality

Globe and Mail

time9 minutes ago

  • Globe and Mail

Imagen Network Builds Adaptive Content Filters Using Grok to Boost Engagement Quality

Imagen integrates Grok intelligence to deliver more responsive feed moderation in decentralized apps. Singapore, Singapore--(Newsfile Corp. - August 7, 2025) - Imagen Network (IMAGE), the decentralized AI-powered social platform, has introduced a new suite of adaptive content filters designed to improve engagement quality across its Web3 environments. This development leverages Grok's intelligent infrastructure to identify context and tone in real-time, providing more precise feed moderation without compromising transparency. Advanced AI tools designed for smarter decentralized social interactions. To view an enhanced version of this graphic, please visit: The new filters support dynamic adjustments based on behavioral feedback and allow communities to retain autonomy while benefiting from advanced moderation. Grok's capabilities are embedded to optimize how user content is evaluated and organized, adapting to conversational shifts and sentiment trends as they occur. This initiative reinforces Imagen's commitment to empowering user-led spaces with scalable AI systems. This upgrade follows Imagen's broader roadmap to streamline on-chain user experiences and enhance social authenticity. By combining Grok's real-time reasoning with decentralized control, the platform strengthens its position as the standard for intelligent, creator-led social networks. About Imagen Network Imagen Network is a decentralized AI platform focused on building user-led social applications that combine personalization, transparency, and smart interaction systems. It enables peer engagement through intelligent tools and adaptive AI systems for the Web3 generation. Media Contact Dorothy Marley KaJ Labs +1 707-622-6168 media@ Social Media Twitter Instagram

Developer and housing researcher debate foreign investment in B.C. real estate
Developer and housing researcher debate foreign investment in B.C. real estate

CBC

time26 minutes ago

  • CBC

Developer and housing researcher debate foreign investment in B.C. real estate

Retired UBC geographer David Ley is one of the 27 signatories of a letter sent to the prime minister taking a stance against foreign investment in housing in B.C. On the other hand, Cressey Development Group is a signatory of an open letter asking for restrictions on foreign investment to be lifted. Ley and Cressey's executive vice-president Hani Lammam join us on On The Coast to debate which approach is better.

Amgen Inc. Reports Strong Q2 2025 Financial Results
Amgen Inc. Reports Strong Q2 2025 Financial Results

Globe and Mail

time39 minutes ago

  • Globe and Mail

Amgen Inc. Reports Strong Q2 2025 Financial Results

Amgen Inc ( (AMGN)) has released its Q2 earnings. Here is a breakdown of the information Amgen Inc presented to its investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Amgen Inc., a leading biotechnology company, specializes in developing innovative medicines for serious diseases, including cancer, heart disease, and rare conditions. In its recent earnings report for the second quarter of 2025, Amgen announced a 9% increase in total revenues, reaching $9.2 billion, with product sales also growing by 9%. The company's GAAP earnings per share saw a significant rise of 92%, driven by increased revenues, while non-GAAP EPS rose by 21%. Key products such as Repatha and EVENITY showed strong double-digit sales growth, and the company continued to invest in its research and development programs, including the promising MariTide studies. Looking ahead, Amgen remains focused on sustainable, long-term growth, with a projected revenue range of $35.0 billion to $36.0 billion for the full year 2025, and continued investment in its robust pipeline of innovative treatments.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store